NL7003555A - - Google Patents

Info

Publication number
NL7003555A
NL7003555A NL7003555A NL7003555A NL7003555A NL 7003555 A NL7003555 A NL 7003555A NL 7003555 A NL7003555 A NL 7003555A NL 7003555 A NL7003555 A NL 7003555A NL 7003555 A NL7003555 A NL 7003555A
Authority
NL
Netherlands
Application number
NL7003555A
Other versions
NL141086B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7003555A publication Critical patent/NL7003555A/xx
Publication of NL141086B publication Critical patent/NL141086B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL7003555A 1969-03-13 1970-03-12 Werkwijze voor het bereiden van een voor parenterale toediening geschikt oxytetracyclinepreparaat. NL141086B (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80712169A 1969-03-13 1969-03-13
US874770A 1970-02-04 1970-02-04

Publications (2)

Publication Number Publication Date
NL7003555A true NL7003555A (cs) 1970-09-15
NL141086B NL141086B (nl) 1974-02-15

Family

ID=26678568

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7003555A NL141086B (nl) 1969-03-13 1970-03-12 Werkwijze voor het bereiden van een voor parenterale toediening geschikt oxytetracyclinepreparaat.

Country Status (8)

Country Link
BE (1) BE747255A (cs)
CY (1) CY656A (cs)
DE (1) DE2011793A1 (cs)
FR (1) FR2034890B1 (cs)
GB (1) GB1250304A (cs)
IE (1) IE34075B1 (cs)
MY (1) MY7300168A (cs)
NL (1) NL141086B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1163197A (en) * 1980-04-10 1984-03-06 Herman Horn Injectable oxytetracycline compositions
US6110905A (en) * 1994-07-09 2000-08-29 Norbrook Laboratories Limited Long-acting oxytetracycline composition
GB9413873D0 (en) * 1994-07-09 1994-08-31 Norbrook Lab Ltd Long-acting oxytetracycline composition
US6310053B1 (en) 1995-07-05 2001-10-30 Norbrook Laboratories Limited Long-acting oxytetracycline composition
CA2609196A1 (en) 2005-05-31 2006-12-07 Warsaw Orthopedic, Inc. Compositions and methods for treating pain
US8945623B2 (en) * 2006-05-03 2015-02-03 Warsaw Orthopedic, Inc. Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use
US8840933B2 (en) 2006-05-03 2014-09-23 Warsaw Orthopedic, Inc. Method of treating neuronal injury by administering magnesium chloride and PEG
US8057458B2 (en) 2006-10-30 2011-11-15 Warsaw Orthopedic, Inc. Method for treating facet pain
US9675696B2 (en) 2006-11-14 2017-06-13 Warsaw Orthopedic, Inc. Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
US8153112B2 (en) 2007-08-03 2012-04-10 Warsaw Orthopedic, Inc. Compositions and methods for treating cavity conditions
US8858924B2 (en) 2009-03-26 2014-10-14 Warsaw Orthopedic, Inc. Compositions and methods for treatment of hemorrhage
US8852566B2 (en) 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
WO2010111212A1 (en) 2009-03-26 2010-09-30 Warsaw Orthopedic, Inc. Methods of identifying potential components for targeted drug delivery compositions
US9244060B2 (en) 2009-03-26 2016-01-26 Warsaw Orthopedic, Inc. Site localization and methods for monitoring treatment of disturbed blood vessels
US9078808B2 (en) 2009-03-26 2015-07-14 Warsaw Orthopedic, Inc. Device to deliver magnesium in PEG formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004894A (en) * 1959-04-07 1961-10-17 Upjohn Co Therapeutic composition comprising tetracycline and a dioxolane
US3140232A (en) * 1962-12-19 1964-07-07 Pfizer & Co C Color stabilization of tetracycline compositions with polypropylene glycols

Also Published As

Publication number Publication date
GB1250304A (cs) 1971-10-20
DE2011793A1 (de) 1970-09-17
FR2034890B1 (cs) 1974-05-24
MY7300168A (en) 1973-12-31
IE34075B1 (en) 1975-01-22
FR2034890A1 (cs) 1970-12-18
CY656A (en) 1972-09-11
BE747255A (fr) 1970-09-14
IE34075L (en) 1970-09-13
NL141086B (nl) 1974-02-15

Similar Documents

Publication Publication Date Title
AU2270770A (cs)
FR2034890B1 (cs)
AU429630B2 (cs)
AU5712069A (cs)
AU2355770A (cs)
CS152376B2 (cs)
AU427401B2 (cs)
AU438128B2 (cs)
AU428131B2 (cs)
AU428129B2 (cs)
AU442285B2 (cs)
AU428074B2 (cs)
AT308690B (cs)
AU417208B2 (cs)
AU425297B2 (cs)
AU470661B1 (cs)
AU410358B2 (cs)
AU414607B2 (cs)
CS151216B1 (cs)
AU4923469A (cs)
AU1036070A (cs)
AU5079269A (cs)
CS148377B1 (cs)
CS150905B2 (cs)
AU5228269A (cs)

Legal Events

Date Code Title Description
SNR Assignments of patents or rights arising from examined patent applications

Owner name: SDS BIOTECH CORPORATION

V1 Lapsed because of non-payment of the annual fee
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: DIAMOND SHAM